Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway.

Xu, Ruisi; Yin, Jian; Zhang, Ying; Zhang, Siqi

Xu, Ruisi; Yin, Jian; Zhang, Ying; Zhang, Siqi.

Affiliation

Xu R; Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
Yin J; Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
Zhang Y; Endoscopy Center, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
Zhang S; Department of Nephrology, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.

J Cell Biochem ; 120(9): 14585-14593, 2019 09.

Article in En | MEDLINE | ID: mdl-30998268

Subject(s)

Annexin A3/genetics; Colorectal Neoplasms/genetics; Down-Regulation; Drug Resistance, Neoplasm; Oxaliplatin/pharmacology; Anthracenes/pharmacology; Cell Line, Tumor; Cell Movement/drug effects; Cell Survival/drug effects; Colorectal Neoplasms/drug therapy; Flavonoids/pharmacology; Gene Expression Regulation, Neoplastic/drug effects; Gene Silencing; HCT116 Cells; Humans; MAP Kinase Signaling System/drug effects

Key words

MAPK signaling pathway; annexin A3; colorectal cancer; oxaliplatin; resistance

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Down-Regulation / Annexin A3 / Drug Resistance, Neoplasm / Oxaliplatin Limits: Humans Language: En Journal: J Cell Biochem Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google